Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-07 Purchase |
2023-06-09 4:26 pm |
Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M Chief Financial Officer |
100,000 | $1.4549 | $145,490 | 100,000 (Direct) |
View |
| 2023-03-15 Sale |
2023-03-17 6:02 pm |
Adverum Biotechnologies Inc. | ADVM | Riley Brigit Chief Scientific Officer |
7,299 | $0.7816 | $5,705 | 117,435 (Direct) |
View |
| 2023-03-15 Sale |
2023-03-17 6:02 pm |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Operating Officer |
13,360 | $0.7816 | $10,442 | 265,891 (Direct) |
View |
| 2023-03-15 Sale |
2023-03-17 6:01 pm |
Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, President and Director |
41,239 | $0.7816 | $32,232 | 692,141 (Direct) |
View |
| 2022-09-19 Sale |
2022-09-21 8:01 pm |
Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer |
4,272 | $1.0697 | $4,570 | 39,061 (Direct) |
View |
| 2022-09-19 Sale |
2022-09-21 8:00 pm |
Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer |
6,058 | $1.0696 | $6,480 | 47,875 (Direct) |
View |
| 2022-09-19 Sale |
2022-09-21 7:59 pm |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section |
13,305 | $1.0697 | $14,232 | 273,251 (Direct) |
View |
| 2022-09-19 Sale |
2022-09-21 7:58 pm |
Adverum Biotechnologies Inc. | ADVM | Riley Brigit Chief Scientific Officer |
7,266 | $1.0697 | $7,772 | 118,734 (Direct) |
View |
| 2022-09-19 Sale |
2022-09-21 7:57 pm |
Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, President and Director |
41,082 | $1.0696 | $43,941 | 727,380 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-03 Option Award |
2023-09-05 4:14 pm |
N/A 2033-08-02 |
Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M Chief Financial Officer |
850,000 | $0 | 850,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:19 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:17 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:15 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Whitcup Scott M Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:13 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:10 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:05 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Lupher Jr. Mark L. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:03 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Hong Soo Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:02 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Machado Patrick Director |
52,500 | $0 | 92,500 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:24 pm |
N/A 2033-02-28 |
Adverum Biotechnologies Inc. | ADVM | Riley Brigit Chief Scientific Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:24 pm |
N/A 2033-02-28 |
Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:23 pm |
N/A 2033-02-28 |
Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:22 pm |
N/A 2033-02-28 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Operating Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:21 pm |
N/A 2033-02-28 |
Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, President and Director |
930,000 | $0 | 930,000 (Direct) |
View |
Ownership |
2022-12-15 5:27 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M Chief Financial Officer |
0 | $0 | 0 (Direct) |
View |
| 2022-09-14 Option Award(A) |
2022-09-21 7:55 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer |
33,333 | $0 | 43,333 (Direct) |
View |
| 2022-09-14 Option Award |
2022-09-16 7:26 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer |
25,000 | $0 | 35,000 (Direct) |
View |
| 2022-09-14 Option Award |
2022-09-16 7:25 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer |
33,333 | $0 | 53,933 (Direct) |
View |
| 2022-09-14 Option Award |
2022-09-16 7:00 pm |
N/A 2032-09-13 |
Adverum Biotechnologies Inc. | ADVM | Riley Brigit Chief Scientific Officer |
164,413 | $0 | 164,413 (Direct) |
View |
| 2022-09-14 Option Award |
2022-09-16 7:00 pm |
N/A 2032-09-13 |
Adverum Biotechnologies Inc. | ADVM | Rakow John SVP, Genl Counsel, Acting CFO |
118,070 | $0 | 118,070 (Direct) |
View |
| 2022-09-14 Option Award |
2022-09-16 6:59 pm |
N/A 2032-09-13 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section |
394,771 | $0 | 394,771 (Direct) |
View |
| 2022-09-14 Option Award |
2022-09-16 6:58 pm |
N/A 2032-09-13 |
Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, President and Director |
1,260,000 | $0 | 1,260,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 4:23 pm |
N/A 2032-06-09 |
Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 4:22 pm |
N/A 2032-06-09 |
Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 4:22 pm |
N/A 2032-06-09 |
Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 4:21 pm |
N/A 2032-06-09 |
Adverum Biotechnologies Inc. | ADVM | Lupher Jr. Mark L. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 4:20 pm |
N/A 2032-06-09 |
Adverum Biotechnologies Inc. | ADVM | Whitcup Scott M Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 4:19 pm |
N/A 2032-06-09 |
Adverum Biotechnologies Inc. | ADVM | Machado Patrick Director |
52,500 | $0 | 52,500 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:39 pm |
N/A 2032-06-07 |
Adverum Biotechnologies Inc. | ADVM | Rakow John SVP, Genl Counsel, Acting CFO |
250,000 | $0 | 250,000 (Direct) |
View |
Ownership |
2022-06-10 4:37 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Rakow John SVP, Genl Counsel, Acting CFO |
0 | $0 | 423,771 (Direct) |
View |
Ownership |
2022-06-07 7:11 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | PECOTA NANCY E Principal Accounting Officer |
0 | $0 | 0 (Direct) |
View |